History of Foreign Studies of Organophosphate Induced Delayed Neuropathy

Сertain organophosphates are highly toxic and can be used as chemical warfare agents. However, some classes of organic phosphorus compounds can cause so-called delayed neurotoxicity. Since the discovery of this phenomenon in 1899, extensive research has been conducted on delayed neurotoxicity caused by organophosphates. Mass poisoning of residents of the United States and Morocco in the last century demonstrated the high danger of substances that cause neurotoxicity, and gave a powerful impetus to research into this phenomenon. In addition to delayed effects, some phosphorus compounds potentiate the action of already known chemical warfare agents, increasing their toxicity by more than 10 times. Research in this direction is conducted under the auspices of the defense departments of the United States, Canada and the Netherlands. The wide distribution of phosphorus compounds in various industries and agriculture, the long hidden period and the irreversibility of lesions caused by neurotoxic organic phosphorus compounds, cause their potential threat to the security of the Russian Federation.

1. Nelga I.A., Medvetsky I.V., Zlobin A.V., et al. Chemical Weapons: History of the Study of Organophosphorus Toxic Agents Abroad // Journal of NBC Protection Corps. 2019. V. 3. № 2. P. 175–193 (in Russian).

2. Lorot C. Les Combinaisons de la Creosote dans le Traitement de la Tuberculose Pulmonaire. These de Paris, 1899.

3. Timperley C.M. Best Synthetic Methods: Organophosphorus (V) chemistry. London: Academic Press, 2015.

4. Smith M.I., Elove E., Valaer P.J. Jr., et al. Pharmacological and chemical studies of the cause of socalled Ginger Paralysis // Public Health Reports. 1930. V. 45. № 30. P. 1703–1716.

5. Smith H.V., Spalding J.M.K. Outbreak of paralysis in morocco due to ortho-cresyl phosphate poisoning // Lancet. 1959. V. 274. № 7110. P. 1019–1021. https://doi.org/10.1016/S0140-6736(59)91486-2

6. Abou-Donia M. Organophosphorus esterindused chronic neurotoxicity // J. Occup. Health Safety. 2005. V. 21. № 5. P. 408–432.

7. Wexler P. Enciclopedia of toxicology. Bethesda: Academic Press, 2014.

8. Harmful Substances in Industry. The Reference Book in Three Volumes. V. 3. Inorganic and Elementorganic Compaunds. Leningrad: Chimiya, 1977 (in Russian).

9. Johnson M.K. Delayed neurotoxic action of some organophosphorus compounds // Br. Med. Bull. 1969. V. 25. № 3. Р. 231–235.

10. Johnson M.K. A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compound // Biochem J. 1969. V. 111. P. 487–495.

11. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compound // Biochem. J. 1969. V. 114. P. 711–717.

12. Chemnitius B.J.M., Haselmeyer K.H., Zech R. Neurotoxic esterase identification of two isoenzymes in hen // Arch. Toxicol. 1983. V. 53. P. 235–244.

13. Prozorovsky V.B., Chepur S.V. New Data on Non-Synaptic (Distant) Effects of Organophosphorus Inhibitors of Cholincsterase (Literature Review) // Toxicological review. 2001. № 4. Р. 2–7 (in Russian).

14. Johnson M.K. Organophosphorus esters causing delayed neurotoxic effect // Arch. Toxicol. 1975. V. 34. P. 259–288.

15. Schrader G. New Organophosphorus Insecticides. Мoscow: Mir, 1965.

16. Francis B.M., Metcalf R.L., Fisher S.W. Response of laboratory rodents to selected avian delayed neurotoxicants // Arch. Environ. Contam. Toxicol. 1983. V. 12. P. 731–738.

17. Eto M., Casida J.E., Eto T. Hydroxylation and cyclization reactions involved in the metabolism of trio- cresyl phosphate // Biochem. Pharmacol. 1962. V. 11. P. 337–352.

18. Aleksandrov V.N., Yemelyanov V.I. Toxic Substances, Мoscow: Military Publishing, 1990 (in Russian).

19. Casida J.E., Eto M., Baron R.L. Biological activity of tri-o-cresy phosphate metabolite // Nature. 1961. V. 191. P. 1396–1397.

20. Polak R.L., Cohen E.M. The influence of triorthocresylphosphate on the distribution of 32P in the body of the rat after the injection of 32P-sarin // Biochem. Pharm. 1969. V. 18. P. 813–820.

21. McKay D.H., Jardine R.V., Adie P.A. The synergistic action of 2-(o-cresyl)-4H-1,3,2- benzodioxaphosphorin-2-oxide with soman and physostigmine // Toxicol. Appl. Pharmacol. 1971. V. 20. P. 474–479.

22. Bošković В. The influence of 2-(o-cresyl)- 4H-1,3,2-benzodioxa-phosphorin-2-oxbde (CBDP) on organophosphate poisoning and its therapy // Arch. Toxicol. 1979. V. 42. P. 207–216.

23. Jokanović M. Role of carboxylesterase in soman, sarin and tabun poisoning in rats // Pharm. Toxicol. 1989. V. 65. P. 181–184.

24. Clement J.G. Importance of aliesterase as a detoxication mechanism for soman (pinacolylmethyl phosphonofluoridate) in mice // Biochem. Pharmacol. 1984. V. 33. № 23. P. 3807–3811.

25. Due A.H. Effect of pretreatment with CBDP on toxicocinetics of soman stereoisomers in rats and guinea pigs // Arch. Toxicol. 1993. V. 67. P. 706–711.

26. Haley R.W., Billecke S., LaDu B.N. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans // Toxicol. Appl. Pharmacol. 1999. V. 157. P. 227–233.

27. Mackness B., Mackness M.I., Arrol S., et al. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon // Brit. J. Pharmacol. 1997. V. 122. P. 265–268.

28. Crouzier D., LeCrom V.B., Four E., et al. Disruption of mice sleep stages induced by low doses of organophosphorus compound soman // Toxicol. 2004. V. 199. P. 59–71.

29. Jalali N., Balali-Mood M., Jalali I., Shakeri M.T. Electrophysiological changes in patients with acute organophosphorous pesticide poisoning // Basic Clin. Pharmacol. Toxicol. 2010. V. 108. P. 251–255.